Aurobindo Pharma's Unit gets USFDA Approval for Cancer Drug

Aurobindo Pharma announced that it’s fully owned subsidiary Eugia Pharma Specialities Ltd has received the USFDA approval for manufacturing and marketing its generic equivalent of ...

Drugs Panel Proposes Curbs on OTC Medicines to Prevent Misuse

India's premier drug advisory panel is in the process of weighing a proposal to limit the over-the-counter sale of frequently used self-medication drugs in a bid to curb abuse and guarantee patient safety, sources familiar with the issue revealed...

Dr Reddy's, Lupin recall drugs in US over labeling, manufacturing flaws

The US health agency has announced that Lupin and Dr. Reddy's Laboratories are recalling items in the US market because of manufacturing and labeling mistakes, respectively.

Gene Solutions, Element Biosciences team up to boost global NGS tech

Element Biosciences, a business that democratizes access to cutting-edge life science solutions, and Singapore-based startup Gene Solutions, which specializes in advanced genetic testing, have formed a strategic partnership

ICMR Calls for Targeted Ban on Popular Painkiller Over Safety Concerns

The Indian Council of Medical Research (ICMR) has instructed a ban on all formulations of the broadly used painkiller Nimesulide above 100 mg. The proposal, which aims at patients under 18 and those aged 60 and above, underscores deep safety concerns

WHO Approves Syngenta's Sovrenta to Combat Malaria-Carrying Bugs

Malaria continues to be one of the greatest killers among the diseases that can be found in the world at the moment; it has evaded and is continuing to spread and become...

Herbalife India unveils Sleep Enhance with saffron for quality rest

Herbalife India, a leading health and wellness company, community, and platform, presents Sleep Enhance, a caffeine-free supplement containing a plant-based, thoroughly researched component that has been demonstrated to enhance sleep quality.

Novo Nordisk to Stop Human Mixtard, Top-Selling Insulin in India

Novo Nordisk has decided to discontinue Human Mixtard—India’s largest-selling insulin—and several other key insulin products, potentially reshaping the country's Rs 5,000 crore insulin market. The action indicates a major shift in the diabetes care

AstraZeneca, Daiichi Sankyo Say Enhertu with Pertuzumab for Breast Cancer

When compared to a taxane, trastuzumab and pertuzumab (THP) as a first-line treatment for patients with HER2-positive metastatic breast cancer, Enhertu (trastuzumab deruxtecan) in combination

NKP Pharma, Rockwell Automation to enhance regulatory compliance

Rockwell Automation, a provider of digital transformation and industrial automation technology, has teamed up with NKP Pharma, a pharmaceutical packaging machinery manufacturer in Gujarat, to introduce a new visualization solution that will enhance

© 2025 India Pharma Outlook. All Rights Reserved.